期刊文献+

人TIMP-1转基因小鼠肾组织内外源基因功能表型的鉴定 被引量:1

Identification of the functional phenotype of transgene in kidneys of human tissue inhibitor of metalloproteinase-1 (TIMP-1) transgenic mice
暂未订购
导出
摘要 目的对人基质金属蛋白酶组织抑制物-1(TIMP-1)转基因小鼠肾组织内外源人TIMP-1基因的功能表型进行鉴定,为深入研究TIMP-1在肾脏疾病进展过程中的病理生理作用奠定基础。方法3月龄野生型小鼠(n=8,正常组)和hTIMP-1转基因小鼠(n=8)肾组织石蜡切片行PAS染色,观察肾脏组织结构变化。采用Northern杂交、Western印迹方法检测两组小鼠肾组织内h/mTIMP-1、mTIMP-1、TIMP-2、TIMP-3、MMP-9、MMP-2和COLⅣα5mRNA及蛋白质表达;明胶酶谱法检测MMP-2、MMP-9的活性。反向酶谱法检测TIMP-1的活性。结果hTIMP-1转基因小鼠与正常组小鼠相比,肾组织结构未见显著变化。与正常组小鼠相比,hTIMP-1转基因小鼠肾组织内h/mTIMP-1mRNA、蛋白表达及活性显著升高(P<0·05);TIMP-2、MMP-2mRNA和蛋白表达降低(P<0·05);MMP-9的活性增高(P<0·05),而MMP-2的活性则降低(P<0·05)。两组小鼠mTIMP-1、TIMP-3、MMP-9和COLⅣα5的mRNA表达没有显著性差异(P>0·05)。结论外源基因在人TIMP-1转基因小鼠肾组织内稳定表达并导致MMPs/TIMPs系统发生代偿性变化。 Objective To thoroughly explore the pathophysiological roles of TIMP-1 during the progressive course of renal diseases, the study was aimed at identifying the functional phenotype of endogenous and exogenous genes in kidneys of human TIMP-1 transgenic mice. Methods Renal histological changes between 3-month-old wild type mice (n=8) and 3-month-old transgenic mice (n=8) were analyzed through PAS staining of paraffin sections. The mRNA and protein expressions of h/mTIMP-1, mTIMP-1, TIMP-2, TIMP-3, MMP-9, MMP-2, and COLⅣa5 mRNA were detected by Northern blot and Western blot. The activities of gelatinases and TIMP-1 were examined by gelatin zymography and reverse zymography, respectively. Results No difference in histological picture in kidneys was found between wild type and transgenic mice. In contrast with wild type mice, it was found that in kidneys of transgenic mice, the mRNA and protein expressions of h/mTIMP-1 and its activity were up-regulated (P〈0. 05), the mRNA and protein expressions of TIMP-2 and MMP-2 were down-regulated (P〈0. 05), and the activity of MMP-9 was up-regulated, however, the activity of MMP-2 was down-regulated (P〈0. 05). There was no significant difference in the mRNA expressions of mTIMP-1, TIMP-3, MMP-9, and COlⅣa5 between the two groups (P〉0. 05). Conclusion The transgene was expressed steadily in kidneys of human TIMP-1 transgenic mice, and it induced the compensation of MMPs/TIMPs.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2006年第3期216-219,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家重点基础研究发展规划(973)项目(G200057003) 国家自然科学基金创新群体科学基金(30121005) 国家自然科学基金(30300161) 北京市自然科学基金(7032045)
关键词 金属蛋白酶 1 组织抑制剂 转基因 tissue inhibitor of metalloproteinase-1 transgene kidney
  • 相关文献

参考文献18

  • 1王建中,陈香美,师锁柱,张燕平,田月.基质金属蛋白酶-9和金属蛋白酶组织抑制物-1在IgA肾病肾组织中的表达[J].中华内科杂志,2002,41(2):75-78. 被引量:48
  • 2Diamond JR,Ricardo SD,Klahr S.Mechanisms of interstitial fibrosis in obstructive nephropathy.Semin Nephrol,1998,18(6):594
  • 3董健平,陈香美,师锁柱,田月.金属蛋白酶组织抑制剂1在大鼠肾小管间质损害中的表达及其意义[J].中华肾脏病杂志,2002,18(4):275-279. 被引量:29
  • 4田玥,刘庆鑫,陈香美,洪权,林洪丽,冯全洲,张雪光.TIMP-1转基因小鼠纯合子的建立及建系[J].中国生物化学与分子生物学报,2003,19(5):558-562. 被引量:5
  • 5Kenagy RD,Nikkari ST,Welgus HG et al.Heparin inhibits the induction of three matrixmetalloproteinases (stromelysin,92-kD gelatinase,and collagenase) in primate arterial smooth muscle cells.J Clin Invest,1994,93(5):1987
  • 6Jernigan SM,Eddy AA.Experimental insights into the mechanisms of tubulointerstitial scarring.In:Mechanisms and Clinical Management of Chronic Renal Failure,2nd Ed,edited by El Nahas AM,Oxford,Oxford University Press,2000,104
  • 7Tang WW,Feng L,Xia Y et al.Extracellular matrix accumulation in immune-mediated tubulointerstitial injury.Kidney Int,1994,45 (4):1077
  • 8Yoshiji H,Kuriyama S,Miyamoto Y et al.Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.Hepatology,2000,32(6):1248
  • 9Kim H,Oda T,Opez-guisa J et al.TIMP 1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.J Am Soc Nephrol,2001,12(4):736
  • 10Roeb E,Winograd R,Breuer B et al.Increased TIMP1 activity results in increased expression of gelatinases and altered cell motility.J Cell Biochem.1999,75(2):346

二级参考文献25

  • 1董健平,陈香美,冯全洲,傅博,田月,王兆霞,林洪丽.反义金属蛋白酶组织抑制剂-1对大鼠肾小管间质损害的治疗作用[J].中华医学杂志,2002,82(9):617-621. 被引量:6
  • 2李文歌,陈香美,师锁柱,郭瑞敏.弥漫型肾间质纤维化小鼠模型的快速制备及实验研究[J].军医进修学院学报,1996,17(3):188-190. 被引量:28
  • 3田小利 陈兰英 等.转基因动物原理,技术与应用[M].长春:吉林科学技术出版社,1994.3-119.
  • 4郝光荣主编.实验动物学[M].上海:第二军医大学出版社,1998.11.
  • 5Schaefer L, Han X, August C, Matzkies, Lorenz T, Schader R M. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metslloproteinase in obese Zucker rats. Diabetalogia ,1997,40(9) : 1035 - 1043.
  • 6Duymelinck C, Deng J T, Dauwe S E,Brce M E,Verpooten G A. Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int, 1998,54(3) :804 - 818.
  • 7Lin H, Chen X, Wang J, Yu Z. Inhihition of apoptois in rat mesangial cells by tissue inhibitor of metalloproteinase-1. Kidney Int, 2002,62(1):60-69.
  • 8Schnaper H W. Balance between matrix synthesis and degradation: a determinant of glomerulosclerosis. Pediar Nehprol , 1995,9(1): 104- 111.
  • 9Shankland S J, Thai HLK, Scholey J W. Glomerular expression fo tissue inhibitor of metalloproteinase (TIMP-1 ) in normal and diabetic rats. J Am Soc Nephrol , 1996,7(1) :97 - 104.
  • 10Kopp J B, Factor V M, Mozes M, Nagy P, Sounderson N, Bottinger EP, Klotman P E, Thorgeirsson S S. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Investig,1996, 74(6) :991 - 1003.

共引文献77

同被引文献11

  • 1Lenz O,Elliot SJ,Stetler-Stevenson WG.Matrix metalloproteinase in renal development and disease.J Am Soc Nephrol,2000,11:574-581.
  • 2BeaudeuxJL,GiralP,Bruckert E,etal.Matrixmetalloproteinases,inflammation and atherosclerosis:therapeutic perspectives.Clin Chem Lab Med,2004,42:121-131.
  • 3Duymelinck C,Dauwe SE,De Greef KE,et al.TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.Kidney Int,2000,58:1186-1201.
  • 4Chromek M,Tullus K,Lundahl J,et al.Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes,protects them from apoptosis,and blocks their transmigration during inflammation.Infect Immun,2004,72:82-88.
  • 5Clayton A,Steadman R.ICAM-1 interactions in the renal interstitium:a novel activator of fibroblasts during nephritis.Histol Histopathol,1999,14:861-870.
  • 6Ritter LM,Garfield SH,Thorgeirsson UP.Tissue inhibitor of metalloproteinases-1 (T IMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells.Biochem Biophys Res Commun,1999,257:494-499.
  • 7Parks WC,Wilson CL,Lopez-Boado YS.Matrix metalloproteinases as modulators of inflammation and innate immunity.Nat Rev Immunol,2004,4:617-629.
  • 8Fiore E,Fusco C,Romero P,et al.Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cellmediated cytotoxicity.Oncogene,2002,21:5213-5223.
  • 9Kridel SJ,Chen E,Kotra LP,et al.Substrate hydrolysis by matrix metalloproteinase-9.J Biol Chem,2001,276:20572-20578.
  • 10董健平,陈香美,师锁柱,田月.金属蛋白酶组织抑制剂1在大鼠肾小管间质损害中的表达及其意义[J].中华肾脏病杂志,2002,18(4):275-279. 被引量:29

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部